1,043
Views
0
CrossRef citations to date
0
Altmetric
Neurology

A new prediction model for giant cell arteritis in patients with new onset headache and/or visual loss

ORCID Icon, , , , , , , , , & show all
Pages 2769-2775 | Received 16 Nov 2021, Accepted 27 Sep 2022, Published online: 21 Oct 2022

References

  • McAlinden C, Ioannidis P, Roberts S, et al. Giant cell arteritis. Lancet. 2014;383(9923):1182. 1182-6736(14)60459-1.
  • Brack A, Martinez‐Taboada V, Stanson A, et al. Disease pattern in cranial and large‐vessel giant cell arteritis. Arthr Rheumat. 1999;42(2):311–317.
  • Gonzalez‐Gay MA, Vazquez‐Rodriguez TR, Lopez‐Diaz MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454–1461.
  • Gonzalez-Gay MA, Martinez-Dubois C, Agudo M, et al. Giant cell arteritis: epidemiology, diagnosis, and management. Curr Rheumatol Rep. 2010;12(6):436–442.
  • Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum. 2001;30(4):249–256.
  • Salvarani C, Pipitone N, Versari A, et al. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol. 2012;8(9):509–521.
  • González‐Gay MA, Blanco R, Rodríguez‐Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthr Rheum. 1998;41(8):1497–1504.
  • Breuer GS, Nesher R, Nesher G. Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol. 2008;26(6):1103–1106.
  • Luqmani R, Lee E, Singh S, et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess. 2016;20(90):1–238.
  • Hunder GG, Bloch DA, Michel BA, et al. The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–1128.
  • Rao JK, Allen NB, Pincus T. Limitations of the 1990 American college of rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med. 1998;129(5):345–352.
  • Buttgereit F, Dejaco C, Matteson EL, et al. Polymyalgia rheumatica and giant cell arteritis: a systematic review. J A M A. 2016;315(22):2442–2458.
  • Kermani TA, Schmidt J, Crowson CS, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthrit Rheumat. 2012;41(6):866–871.
  • Biousse V, Newman NJ. Ischemic optic neuropathies. N Engl J Med. 2015;372(25):2428–2436.
  • Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983;286(6361):266.
  • Schmidt WA. Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology (Oxford). 2018;57(suppl_2):ii22–ii31.
  • Lie JT. Temporal artery biopsy diagnosis of giant cell arteritis: lessons from 1109 biopsies. Anat Pathol. 1996;1:69–97.
  • Aschwanden M, Daikeler T, Kesten F, et al. Temporal artery compression sign–a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med. 2013;34:47–50.
  • Coath FL, Chetan Mukhtyar C. Ultrasonography in the diagnosis and follow-up of giant cell arteritis. Rheumatology (Oxford). 2021;60(6):2528–2536.